Backlinks
| Referring page | DR | Ref. domains | Linked domains | Anchor and target URL |
|---|---|---|---|---|
|
slower-cancer-growth-after-venetoclax-rituximab-treatment...
https://bpno.no/medtalks/slower-cancer-growth-after-venetoclax-rituximab-treatment-in-patients-with-cll
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
robin-christensen
https://bpno.no/author/robin-christensen
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
inger-pauline-landsem
https://bpno.no/author/inger-pauline-landsem
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
ectrims25
https://bpno.no/tag/ectrims25
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
news-from-eha23-a-promising-treatment-option-for-follicul...
https://bpno.no/medtalks/news-from-eha23-a-promising-treatment-option-for-follicular-lymphoma
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
f-calprotectin-associeret-med-mucosal-inflammtorisk-aktiv...
https://bpno.no/medtalks/f-calprotectin-associeret-med-mucosal-inflammtorisk-aktivitet-ved-colitis-ulcerosa
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
new-data-for-treatment-of-papillary-renal-cell-carcinoma
https://bpno.no/medtalks/new-data-for-treatment-of-papillary-renal-cell-carcinoma
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
cabozantinib-significantly-prolongs-pfs-compared-to-sunit...
https://bpno.no/artikler/cabozantinib-significantly-prolongs-pfs-compared-to-sunitinib-in-papillary-rcc
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
laegemidler-med-virkning-paa-il-20-cytokin-familien
https://bpno.dk/artikler/laegemidler-med-virkning-paa-il-20-cytokin-familien
bpno.dk
|
15 | 17 | 37 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
the-microbiome-and-rodent-models-of-immune-mediated-diseases
https://bpno.dk/medtalks/the-microbiome-and-rodent-models-of-immune-mediated-diseases
bpno.dk
|
15 | 17 | 37 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
post-transplantasjons-diabetes-hos-organtransplanterte
https://bpno.no/artikler/post-transplantasjons-diabetes-hos-organtransplanterte
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
real-world-insights-on-belantamab-mafodotin-in-rrmm
https://bpno.fi/medtalks/real-world-insights-on-belantamab-mafodotin-in-rrmm
bpno.fi
|
43 | 3 | 40 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
the-covid-19-pandemic-how-do-we-produce-firm-evidence-for...
https://bpno.fi/artikkelit/the-covid-19-pandemic-how-do-we-produce-firm-evidence-for-the-treatment-of-a-novel-disease
bpno.fi
|
43 | 3 | 40 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
hormone-replacement-therapy-and-non-hormonal-treatments-f...
https://bpno.no/medtalks/hormone-replacement-therapy-and-non-hormonal-treatments-for-menopause
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
nordic-breast-cancer-network-webinar-2025
https://bpno.no/events/nordic-breast-cancer-network-webinar-2025
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
hva-vet-vi-om-atrieflimmer-og-risiko-for-hjerneslag-hos-p...
https://bpno.no/artikler/hva-vet-vi-om-atrieflimmer-og-risiko-for-hjerneslag-hos-pasienter-med-hypertrofisk-kardiomyopati
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
esmo-highlights-practical-changes-for-treatment-of-lower-...
https://bpno.fi/medtalks/esmo-highlights-practical-changes-for-treatment-of-lower-gastrointestinal-tumors
bpno.fi
|
43 | 3 | 40 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
tema-om-immunterapi-februar-marts-april-2021
https://bpno.dk/artikler/tema-om-immunterapi-februar-marts-april-2021
bpno.dk
|
15 | 17 | 37 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
kronisk-fatigue-etter-kreft-i-ung-voksen-alder
https://bpno.no/artikler/kronisk-fatigue-etter-kreft-i-ung-voksen-alder
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
physiological-hypoxia-improves-growth-and-l-differentiati...
https://bpno.fi/medtalks/physiological-hypoxia-improves-growth-and-l-differentiation-of-human-colonoids
bpno.fi
|
43 | 3 | 40 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
optimizing-the-front-line-parp-inhibitor-treatment-of-ova...
https://bpno.no/medtalks/optimizing-the-front-line-parp-inhibitor-treatment-of-ovarian-cancer-from-a-nordic-perspective
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
management-of-erdafitinib-a-pan-fgfr-kinase-inhibitor-tre...
https://bpno.fi/medtalks/management-of-erdafitinib-a-pan-fgfr-kinase-inhibitor-treatment-emergent-adverse-events
bpno.fi
|
43 | 3 | 40 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
icml-2019-lugano-nordic-highlights-evening
https://bpno.no/events/icml-2019-lugano-nordic-highlights-evening
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
mansoor-raza-mirza-esmo-is-the-meeting-which-brings-new-d...
https://bpno.no/medtalks/mansoor-raza-mirza-esmo-is-the-meeting-which-brings-new-data-for-forever-practice-changing-trials
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
wclc2021-combining-ipilimumab-plus-pembrolizumab-did-not-...
https://bpno.no/medtalks/wclc2021-combining-ipilimumab-plus-pembrolizumab-did-not-add-clinical-benefit-for-patients-nsclc
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
risk-of-mortality-in-patients-with-systemic-lupus-erythem...
https://bpno.no/artikler/risk-of-mortality-in-patients-with-systemic-lupus-erythematosus
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
patient-reported-outcomes-pro-redskab-til-kvalitetssikring
https://bpno.dk/artikler/patient-reported-outcomes-pro-redskab-til-kvalitetssikring
bpno.dk
|
15 | 17 | 37 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
arsenic-trioxide-induced-oral-manifestations-a-case-of-va...
https://bpno.fi/artikkelit/arsenic-trioxide-induced-oral-manifestations-a-case-of-vallate-papillae-swelling
bpno.fi
|
43 | 3 | 40 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
skin-cancer-incidence-and-mortality-according-to-dermatol...
https://bpno.no/artikler/skin-cancer-incidence-and-mortality-according-to-dermatologist-density-and-population-risk-factors
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
there-is-definitely-a-need-for-novel-treatments-for-elder...
https://bpno.dk/medtalks/there-is-definitely-a-need-for-novel-treatments-for-elderly-patients-with-mantle-cell-lymphoma
bpno.dk
|
15 | 17 | 37 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
mikkel
https://bpno.dk/author/mikkel
bpno.dk
|
15 | 17 | 37 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
resultaterne-fra-solar-1-lover-godt-for-alpelisib-plus-fu...
https://bpno.no/artikler/resultaterne-fra-solar-1-lover-godt-for-alpelisib-plus-fulvestrant-til-patienter-med-hr-positiv-her2-negativ-avanceret-brystkraeft-med-pi3kca-mutationer
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
praktisk-handtering-av-ak-behandling
https://bpno.no/medtalks/praktisk-handtering-av-ak-behandling
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
meet-the-experts-brystcancer-2022
https://bpno.dk/publikationer/meet-the-experts-brystcancer-2022
bpno.dk
|
15 | 17 | 37 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
covid-19-perspectives-from-three-international-leading-ge...
https://bpno.fi/artikkelit/covid-19-perspectives-from-three-international-leading-general-medical-journals-2
bpno.fi
|
43 | 3 | 40 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
a-new-classification-system-for-perianal-fistulising-croh...
https://bpno.no/medtalks/a-new-classification-system-for-perianal-fistulising-crohns-disease
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
prophylactic-treatment-lowers-skin-toxicity-in-nsclc-pati...
https://bpno.no/medtalks/prophylactic-treatment-lowers-skin-toxicity-in-nsclc-patients-on-amivantamab-lazertinib
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
vaccinations-do-not-increase-the-risk-of-relapses-in-mult...
https://bpno.fi/medtalks/vaccinations-do-not-increase-the-risk-of-relapses-in-multiple-sclerosis
bpno.fi
|
43 | 3 | 40 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
gene-signature-of-drug-response-in-ad-predicts-drug-repur...
https://bpno.no/medtalks/gene-signature-of-drug-response-in-ad-predicts-drug-repurpose-in-asthma
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
borderline-ovarian-tumors-increase-risk-of-some-non-ovari...
https://bpno.no/artikler/borderline-ovarian-tumors-increase-risk-of-some-non-ovarian-cancers
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
the-impact-of-the-molecular-profile-and-treatment-of-olde...
https://bpno.no/medtalks/the-impact-of-the-molecular-profile-and-treatment-of-older-and-fragile-patients-with-relapsed-refractory-flt3-mutated-aml
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
the-mced-blood-test-a-possible-new-era-of-early-cancer-de...
https://bpno.no/medtalks/the-mced-blood-test-a-possible-new-era-of-early-cancer-detection
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
optimal-patient-population-in-the-javelin-bladder-100-trial
https://bpno.dk/medtalks/optimal-patient-population-in-the-javelin-bladder-100-trial
bpno.dk
|
15 | 17 | 37 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
key-updates-in-mantle-cell-lymphoma-from-ash-2023
https://bpno.fi/medtalks/key-updates-in-mantle-cell-lymphoma-from-ash-2023
bpno.fi
|
43 | 3 | 40 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
har-pasienter-som-rapporterer-barndomstraumer-forandringe...
https://bpno.no/artikler/har-pasienter-som-rapporterer-barndomstraumer-forandringer-i-stressresponsen-som-voksne
bpno.no
|
11 | 6 | 113 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
the-ultimate-proof-that-immunotherapy-can-be-curative-for...
https://bpno.fi/artikkelit/the-ultimate-proof-that-immunotherapy-can-be-curative-for-metastatic-malignant-melanoma
bpno.fi
|
43 | 3 | 40 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
|
greetings-from-aad-in-new-orleans
https://bpno.dk/artikler/greetings-from-aad-in-new-orleans
bpno.dk
|
15 | 17 | 37 |
(no anchor)
https://bpno.se/
DOFOLLOW
|
Frequently Asked Questions
How many backlinks does bpno.se have?
The backlinks page for bpno.se shows all individual inbound links discovered in our crawl of the web. Each backlink represents a hyperlink on another website that points to a page on bpno.se. Use the filters to narrow results by dofollow/nofollow status, domain rating, or anchor text.
What is a backlink?
A backlink is a hyperlink on one website that points to a page on a different website. Backlinks are one of the most important ranking factors in search engine algorithms because they act as votes of confidence from other sites. The more high-quality backlinks a domain has, the more authority search engines assign to it.
Are the backlinks to bpno.se dofollow or nofollow?
Backlinks to bpno.se include both dofollow and nofollow links. Dofollow links pass link equity (ranking power) to the target site, while nofollow links include a rel="nofollow" attribute that tells search engines not to pass authority. Both types contribute to a natural backlink profile, but dofollow links carry more SEO weight. You can filter by link type using the rel filter above the table.
How often is backlink data updated?
Backlink data is updated monthly when our web crawler completes a new cycle. Our pipeline processes billions of web pages to discover new backlinks, track lost links, and update domain authority scores. The freshness of data depends on when our crawler last visited the referring pages.